SUBSCRIBERS
Drug switch study bolsters case for using copies of biotech medicine
Published Wed, Jun 10, 2015 · 09:50 PM
London
NEW clinical data has bolstered the case for using cheaper copies of expensive biotech drugs by showing that patients with rheumatic diseases can be safely and effectively switched from original-brand medicine to a lower-cost version.
While the first copies of a blockbuster antibody drug for rheumatoid arthritis are now on sale in Europe, such so-called biosimilars have so far been used mainly in new patients, given…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Toymaker Hasbro posts quarterly profit beat, slower sales decline
Hilton lifts 2024 profit forecast on international travel demand
China knockoff raid jolts a global throng of fake-fashion influencers
Roche cuts pipeline after research setbacks and sales drop
Cordlife customers push for legal action
Apparel company Express seeks quick bankruptcy sale